Sonoma Pharmaceuticals annual meeting draws 2,082,799 shares represented by proxy

Sonoma Pharmaceuticals held its annual shareholder meeting on Sept. 16, 2026.

• Shareholders backed the appointment of Frazier & Deeter as independent registered public accounting firm for the fiscal year ending March 31, 2027.
• Investors also authorized an adjournment to allow additional proxy solicitation if needed to secure sufficient votes on meeting items.